Is Hexo (TSX:HEXO) Stock a Buy at its Current Price?

Do you need to consider Hexo stock after its 80% decline since April 2019?

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

We know that cannabis companies have lost considerable value in the last 15 months. Shares of Hexo (TSX:HEXO)(NYSE:HEXO) are currently trading at $1.97 and have lost over 80% since April 2019.

While a few pot stocks have made a comeback in 2020, Hexo has fallen 8.5% year to date. So, why has Hexo been one of the worst-performing pot stocks? Well, similar to peer marijuana companies, Hexo has been impacted by lower-than-expected demand for recreational cannabis products.

Product demand has been subdued due to the slow rollout of retail stores coupled with the cannibalization from illegal sales. Marijuana companies lost market value due to regulatory issues and the vaping scandal as well.

Hexo stock lost 23% in market value on October 10 last year after the company announced preliminary fiscal fourth quarter of 2019 results (year ended in July). Hexo’s sales forecast between $14.5 million and $16.5 million for Q4 was significantly lower than consensus estimates of $25.28 million.

What next for Hexo investors?

In order to take on competition from the illegal market, Hexo launched a low-cost product from its Original Stash brand. It remains to be seen if this move will boost top-line growth significantly for the firm.

The legalization of cannabis-infused edible products is also expected to positively impact sales. The North American market for these products is estimated at $1.56 billion, while the global cannabis-infused beverage market is expected to reach $5.04 billion.

The company’s press release stated, “We continue to prepare to take advantage of opportunities in the cannabis derivatives market and are expecting to launch new products in Canada during the first half of 2020. Products that we intend to introduce include, but are not limited to vapes, edibles such as confectionary and baked goods, cosmetics, and non-alcoholic beverages through our venture with Molson Coors Canada.”

Hexo continues to increase distribution and market penetration across Canada. It has supply agreements with government-run and private retailers in all Canadian provinces and can access 98% of the country’s populace.

Hexo continues to raise capital to support growth. On January 2, 2020, Hexo closed a registered direct offering with institutional investors. Hexo offered 1.49 million shares at an offer price of US$1.67 per share for proceeds of $25 million. It then raised US$20 million on January 22, as it sold 1.19 million shares at an offer price of US$1.67 per share.

Hexo trading at an attractive valuation

Due to its steep decline, Hexo stock is trading at an attractive valuation. It is valued at $506 million, or 6.2 times 2020 sales. It has price-to-book ratio of 0.69.

Analysts expect sales to rise by 70.6% to $81.1 million in 2020 and by 108.4% to $169 million in 2021. We can see that the valuation multiples are more than reasonable considering the company’s growth metrics.

Hexo stock will be volatile, and the upcoming results of cannabis giants, including Aurora Cannabis and Canopy Growth, will be critical for the pot sector as a whole. Analysts tracking Hexo have a 12-month price target of $2.6, indicating upside potential of 32%.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »